AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Angiogenesis relates to recurrence in women with breast cancer.

Women's Health Weekly

| April 10, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 APR 10 - (NewsRx.com & NewsRx.net) -- Angiogenesis relates to recurrence in women with breast cancer.

"Tumor angiogenic activity is an important process linked to tumor growth, metastasis, and invasion. in the present study we investigated whether intratumoral microvessel density (MVD), as assessed with immonohistochemistry, is of prognostic relevance in a series of 77 breast cancer patients with node-negative disease," researchers in Greece report.

"The mean MVD in the hot spots ranged from 9 to 106 (median 31) vessels per x200 optical field. Patients were grouped into 3 categories of low (27 pts), medium (26 pts), and high (24 pts) MVD," wrote M.I. Koukourakis and colleagues, Tumor and Angiogenesis Research Group.

"Angiogenesis was not related to the primary tumor dimensions (T-stage) or the histology differentiation. An inverse association of MVD with estrogen receptor (ER) expression was noted (p=0.0007), while high MVD was directly related to c-erbB-2 overexpression (p=0.04) and high MIB1 proliferation index (p=0.02)," said researchers.

"In univariate and ...

Related articles from newspapers, magazines, journals, and more
Global Academic Cancer Research Group to Initiate Largest Early Stage Breast...
Press release article from: PR Newswire December 7, 2000 700+ words
...and a biologic modifier for breast cancer (known as adjuvant therapy...clinical investigators, the Breast Cancer International Research Group (BCIRG). The studies will...particular type of aggressive breast cancer, in which a gene called...
Genomic Health Announces Study Confirming Prognostic Value of Oncotype DX(R)...
Press release article from: PR Newswire April 20, 2009 700+ words
...Researchers from the Japan Breast Cancer Research Group presented results in an...presentation at the 2009 Kyoto Breast Cancer Consensus Conference International...a director of the Japan Breast Cancer Research Group. "Based on these results...
ABRAXANE Approved for Advanced Breast Cancer Patient Treatment in Quebec.
News wire article from: The America's Intelligence Wire June 29, 2009 700+ words
...needed new treatment option for breast cancer," said Dr. Andre Robidoux, Director of the Breast Cancer Research Group of the CHUM Research Center...approved to treat metastatic breast cancer." The Conseil's approval...
Findings from L.S. Velentzis and co-authors provide new insights into breast...
Newspaper article from: OBGYN & Reproduction Week June 15, 2009 700+ words
...Journal of Cancer (Lignans and breast cancer risk in pre- and post-menopausal...contact L.S. Velentzis, UCL, Breast Cancer Research Group, Dept. of Surgery, Charles...London, Alternative Medicine, Breast Cancer, Breast Carcinoma, Endocrinology...
Genomic Health announces study confirming prognostic value of Oncotype DX...
News wire article from: Chemical Business Newsbase April 20, 2009 700+ words
...receptor-positive early-stage breast cancer as having a low likelihood...Researchers from the Japan Breast Cancer Research Group presented results in an oral presentation at the 2009 Kyoto Breast Cancer Consensus Conference International...
Taxotere(R) (Docetaxel) Receives 2 New European Approvals For Treatment of...
Press release article from: PR Newswire January 11, 2005 700+ words
...operable node- positive breast cancer. A second granted TAXOTERE...patients with metastatic breast cancer whose tumors over-express...analysis from the pivotal Breast Cancer International Research Group (BCIRG) 001/TAX 316...
US Oncology Taking Part in One of the Largest Clinical Trials for Early Stage...
Press release article from: Business Wire June 28, 2002 700+ words
...for women with early stage breast cancer. US Oncology is one of the...clinical investigators -- the Breast Cancer International Research Group (BCIRG). The study is...particular type of aggressive breast cancer in which a gene called HER2...
Key Herceptin Data Presented at San Antonio Breast Cancer Symposium.
Press release article from: PR Newswire December 14, 2006 700+ words
...patients with HER2-positive breast cancer. The study also explored...Genentech, and conducted by the Breast Cancer International Research Group (BCIRG). Phase III TAnDEM...positive. HER2-positive breast cancer occurs in approximately 25...
Phase III Trials Underway Evaluating Herceptin in Early Stage Breast Cancer;...
Press release article from: Business Wire December 8, 2000 700+ words
...benefit women with early stage breast cancer. We urge women with early...President of the National Breast Cancer Coalition. Background on...Bowel Project (NSABP), the Breast Cancer International Research Group (BCIRG), and the North...
Taxotere(R) Study Shows Improved Survival And Reduced Relapse In Early-Stage...
Press release article from: PR Newswire December 6, 2003 700+ words
...women with early-stage breast cancer and reduced their risk of...standard treatment. The Breast Cancer International Research Group (BCIRG) 001/ TAX 316 study...presented at the San Antonio Breast Cancer Symposium on December 5...
For more facts and information, see all results

Source: HighBeam Research, Angiogenesis relates to recurrence in women with breast cancer.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA